Literature DB >> 12694242

The eosinophilias, including the idiopathic hypereosinophilic syndrome.

Finella Brito-Babapulle1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12694242     DOI： 10.1046/j.1365-2141.2003.04195.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  32 in total

1.  A locus for eosinophilia in the MES rat is on Chromosome 19.

Authors:  Guixin Li; Zhanjun Guo; Keiichi Higuchi; Masatomo Kawakubo; Kiyoshi Matsumoto; Masayuki Mori
Journal:  Mamm Genome       Date:  2005-07       Impact factor: 2.957

Review 2.  Best practice in primary care pathology: review 7.

Authors:  W S A Smellie; J Forth; S R S Smart; M J Galloway; W Irving; D Bareford; P O Collinson; K G Kerr; G Summerfield; P J Carey; Rubin Minhas
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

3.  Eosinophilic myocarditis mimicking acute coronary syndrome secondary to idiopathic hypereosinophilic syndrome: a case report.

Authors:  Reza Amini; Craig Nielsen
Journal:  J Med Case Rep       Date:  2010-02-06

4.  Hypereosinophilic syndrome associated with acute necrotizing myocarditis and cardiomyopathy.

Authors:  M Huntgeburth; M Lindner; J W U Fries; U C Hoppe
Journal:  Z Kardiol       Date:  2005-11

Review 5.  Primary eosinophilic disorders: a concise review.

Authors:  Animesh Pardanani; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2008-01       Impact factor: 3.952

6.  Myocarditis during acute schistosomiasis in two travelers.

Authors:  Loïc Epelboin; Stéphane Jauréguiberry; Jean-Baptiste Estève; Martin Danis; Michel Komajda; François Bricaire; Eric Caumes
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

Review 7.  Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis.

Authors:  Jason Gotlib
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

8.  Combined immunodeficiency associated with DOCK8 mutations.

Authors:  Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su
Journal:  N Engl J Med       Date:  2009-09-23       Impact factor: 91.245

Review 9.  Imatinib therapy in clonal eosinophilic disorders, including systemic mastocytosis.

Authors:  Ayalew Tefferi; Animesh Pardanani
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

Review 10.  Eosinophilic Gastroenteritis and Colitis: a Comprehensive Review.

Authors:  Vikas Uppal; Portia Kreiger; Erika Kutsch
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.